Earnings Feed
Start Free
Home/Filings/4/0001304930-07-000012
4//SEC Filing

MILLENNIUM PHARMACEUTICALS INC 4

Accession 0001304930-07-000012

CIK 0001002637operating
View on SEC.govCompany Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 11:23 AM ET

Size

16.8 KB

Accession

0001304930-07-000012

Insider Transaction Report

Form 4
Period: 2007-11-05
MILLENNIUM PHARMACEUTICALS INCMLNM
Keating Laurie B.
SVP and General Counsel
Transactions
  • Exercise/Conversion

    Common stock

    2007-11-05$8.41/sh+25,000$210,250→ 130,162 total
  • Sale

    Common stock

    2007-11-05$12.67/sh−14,522$183,994→ 115,640 total
  • Sale

    Common stock

    2007-11-05$12.66/sh−1,000$12,660→ 107,840 total
  • Sale

    Common stock

    2007-11-05$12.65/sh−1,878$23,757→ 105,162 total
  • Sale

    Common stock

    2007-11-05$12.69/sh−2,000$25,380→ 108,840 total
  • Sale

    Common stock

    2007-11-05$12.68/sh−4,800$60,864→ 110,840 total
  • Sale

    Common stock

    2007-11-05$12.70/sh−800$10,160→ 107,040 total
  • Exercise/Conversion

    Employee stock option (right to buy)

    2007-11-05−25,000→ 6,401 total
    Exercise: $8.41Exp: 2015-03-03→ Common stock (25,000 underlying)
Holdings

  • Common stock

    (indirect: By 401(k))
    2,301
Footnotes (1)
  • [F1]Became exercisable for 1/48th of the number of shares granted monthly beginning 04/03/2005 through 02/03/2007 and for 25/48ths of the shares on 03/03/2007.

Documents

1 file

Issuer

MILLENNIUM PHARMACEUTICALS INC

CIK 0001002637

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001002637

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 11:23 AM ET
Size
16.8 KB
View on SEC.gov